Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study

Fig. 2

Antigen Presentation Assay, CD80 and MHC-II Expression. Thirteen autologous cancer vaccines (ACV), media only control, glutaraldehyde-fixed (GFT) cell only control and MIM-SIS only control. a MHC-II+ single stained cell percentage of total live cells, individual ACV preparations plotted; data represent mean ± SD, n = 3. b MHC-II+ single stained cell percentage of total live cells, pooled ACV preparations plotted; data represent mean ± SD, n = 3 (controls) and n = 39 (ACV). c CD80 + single stained cell percentage of total live cells, individual ACV preparations plotted; data represent mean ± SD, n = 3. d CD80+ single stained cell percentage of total live cells, pooled ACV preparations plotted; data represent mean ± SD, n = 3 (controls) and n = 39 (ACV). e MHC-II + CD80 + double stained cell percentage of total live cells, individual ACV preparations plotted; data represent mean ± SD, n = 3. (F) MHC-II + CD80 + double stained cell percentage of total live cells, pooled ACV preparations plotted; data represent mean ± SD, n = 3 (controls) and n = 39 (ACV). Statistical comparisons are based on one-way ANOVA, followed by post hoc Tukey’s pairwise comparisons. The asterisks denote statistical significance at the level of * p < 0.05, ** p < 0.01, *** p < 0.001. ANOVA, analysis of variance; SD, standard deviation

Back to article page